$PRAN News U.S. stocks

New Post Public Reply Private Reply Replies (0) Message Board

Dec 8, 2014 at 12:20 PM

$PRAN News

U.S. stocks rise; S&P 500, Nasdaq notch quarterly gains
3:47 p.m. March 31, 2014
- Anora Mahmudova

Keurig biggest S&P 500 loser; BlackBerry extends losses
2:30 p.m. March 31, 2014
- Sue Chang

Biotech's shares fall 70% on tests

11:39 a.m. March 31, 2014
- Russ Britt

U.S. stock futures extend gains ahead of Yellen
7:58 a.m. March 31, 2014
- Barbara Kollmeyer

U.S.-listed shares of Prana sink after drug trial
6:50 a.m. March 31, 2014
- Saumya Vaishampayan

Prana sinks 62% after Alzheimer's study fails
6:22 a.m. March 31, 2014
- Barbara Kollmeyer

U.S. stocks edge up; Nasdaq gains for 8th day in a row
4:38 p.m. Feb. 18, 2014
- Anora Mahmudova

Forest Laboratories, Actavis surge on buyout deal
4:11 p.m. Feb. 18, 2014
- Sue Chang

S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap

4:06 p.m. Feb. 18, 2014
- blogs.marketwatch.com

Prana's wild ride continues with shares surging on drug test results

3:24 p.m. Feb. 18, 2014
- Russ Britt

Prana's Huntington disease therapy meets endpoints
11:51 a.m. Feb. 18, 2014
- MarketWatch.com

Prana Biotechnology up 19% in premarket
8:58 a.m. Dec. 6, 2012
- Steve Gelsi

Prana has OK for Alzheimer's study; shares rise
1:30 p.m. Nov. 22, 2011
- MarketWatch.com

Monday’s biggest gaining and declining stocks
3:30 p.m. Sept. 19, 2011
- Laura Mandaro

Prana, European drug makers lead rally
2:26 p.m. April 20, 2011
- Val Brickates Kennedy

Prana climbs 14% on business update
10:18 a.m. April 20, 2011
- Val Brickates Kennedy

Xoma, Prana lead biotech stocks south
12:19 p.m. March 23, 2011
- Val Brickates Kennedy

Tuesday’s biggest gaining and declining stocks
3:56 p.m. March 22, 2011
- Kate Gibson

Prana shines in drugstock trading
10:02 a.m. March 22, 2011
- Val Brickates Kennedy

Prana rockets on Alzheimer's study
9:20 a.m. March 22, 2011
- Val Brickates Kennedy

Genervon ALS drug shows encouraging results

7:27 a.m. Oct. 20, 2014
- Seeking Alpha

Horizon Pharma's Actimmune Gets Orphan Drug Designation - Analyst Blog

1:00 p.m. Oct. 7, 2014
- Zacks.com

Prana Biotechnology Up on Orphan Drug Status for PBT2 - Analyst Blog

4:35 p.m. Sept. 8, 2014
- Zacks.com

Why Prana Biotechnology (PRAN) Stock Is Surging Today

8:46 a.m. Sept. 5, 2014
- TheStreet.com

Why Prana Biotechnology (PRAN) Stock Is Surging Today

1:05 p.m. July 17, 2014
- TheStreet.com

Prana shares up premarket on clinical trial update

8:22 a.m. July 17, 2014
- Seeking Alpha

Prana Biotechnology (PRAN) Stock Suddenly Surges

2:28 p.m. May 27, 2014
- TheStreet.com

Prana Biotechnology Is Still A Short After Recent Alzheimer's Failure

3:15 p.m. April 14, 2014
- Seeking Alpha

Are These Three Biotech Companies Still Worth A Gamble?

10:16 a.m. April 14, 2014
- Seeking Alpha

Prana collapses after trial fails

5:57 a.m. March 31, 2014
- Seeking Alpha

Prana Biotechnology - A Gamble Worth Taking For Both Long- And Short-Term Investors

2:49 p.m. March 20, 2014
- Seeking Alpha

Prana to join Aussie index for top 300 companies

9:00 a.m. March 11, 2014
- Seeking Alpha

Alzheimer's Research Stocks - Technical And Other Considerations

8:38 a.m. March 7, 2014
- Seeking Alpha

Prana Biotech Alzheimer approach supported by study

10:49 a.m. March 6, 2014
- Seeking Alpha

Alzheimer's Dementia: Eli Lilly's Solanezumab Or Prana's PBT2, Which Would You Take?

3:24 p.m. March 4, 2014
- Seeking Alpha

Prana: Right Drug, Wrong Dose

9:38 a.m. March 3, 2014
- Seeking Alpha

Bipolar Prana: PBT2 For Alzheimer's Dementia, Implications Of The Upcoming IMAGINE Trial Results

6:45 a.m. March 1, 2014
- Seeking Alpha

Following The Latest In Alzheimer's Research As An Investor

10:12 a.m. Feb. 24, 2014
- Seeking Alpha

Positive Phase 2 Results For Prana Biotechnology In Huntington's Disease: Behind The Smoke And Mirrors

12:45 p.m. Feb. 22, 2014
- Seeking Alpha

SA PRO: Top Long And Short Ideas, Thursday February 20

7:30 a.m. Feb. 21, 2014
- Seeking Alpha

The Lancet Neurology Publishes Prana's Huntington
Disease Trial
11:01 a.m. Nov. 19, 2014
- BusinessWire - BZX

Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma
8:15 a.m. Sept. 11, 2014
- PR Newswire - PRF

Prana receives FDA Orphan Drug Designation for PBT2 for Huntington Disease
6:45 a.m. Sept. 5, 2014
- PR Newswire - PRF

Prana Alzheimer's disease Development Program update
3:10 p.m. July 17, 2014
- PR Newswire - PRF

Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics
6:04 a.m. July 14, 2014
- PR Newswire - PRF

Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals
4:10 a.m. July 14, 2014
- PR Newswire - PRF

Stock Watchout on Biotech Industry -- Research on Isis Pharma, Pharmacyclics, Amarin, and Prana Biotechnology
6:10 a.m. June 11, 2014
- PR Newswire - PRF

Biotech Equities Coverage -- Research on Isis Pharma, Pharmacyclics, Prana Biotech, and United Therapeutics
10:29 a.m. May 19, 2014
- PR Newswire - PRF

World leader in movement disorders Professor Ira Shoulson joins Prana Board
6:30 a.m. May 14, 2014
- PR Newswire - PRF

Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games
10:34 a.m. April 23, 2014
- PR Newswire - PRF

Zeldes Haeggquist & Eck LLP Announces Investigation of Prana
Biotechnology Limited
8:03 a.m. April 23, 2014
- BusinessWire - BZX

Prana Biotechnology Stock Hits New Low
9:47 a.m. April 16, 2014
- ACCESSWIRE

FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin
8:49 a.m. April 2, 2014
- ACCESSWIRE

Coca-Cola Falls as Soda Sales Drop for 9th Straight Year
1:00 a.m. April 1, 2014
- ACCESSWIRE

Prana Biotechnology announces preliminary results of Phase 2 IMAGINE trial of PBT2 in Alzheimer's disease
6:05 a.m. March 31, 2014
- PR Newswire - PRF

Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health
11:19 a.m. March 28, 2014
- PR Newswire - PRF

Huntington's Reviewed by NeuroPerspective
8:30 a.m. March 4, 2014
- PR Newswire - PRF

Forest Labs to be acquired by Actavis for $25 billion while Prana Biotech surges on drug results
12:23 a.m. Feb. 19, 2014
- ACCESSWIRE

Prana Meets Primary Endpoint in Phase 2 REACH2HD Clinical Study of PBT2 for Treating Huntington Disease
6:02 a.m. Feb. 18, 2014
- PR Newswire - PRF

Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana
8:00 a.m. Dec. 20, 2013
- PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bloomberg Tax Celebrates Global Tax Leaders at IFA

Spotlight on Global Tax Leadership Here's a twist for you: tax law may not scream excitement, but when international tax changemakers get recognized, even the unflappable have to nod in appreciation. Bloomberg Tax just tossed accolades at five distinguished authors who are mapping the complexities of international tax landscapes. This isn't just about numbers—it's...

Lincoln Educational Faces Class Action for Stock Drop

What's Gripping Lincoln Educational Services? You ever feel like you've stepped into a financial thriller with these education stocks? Well, Lincoln Educational Services (NASDAQ:LINC) is at the heart of one, facing the heat of a class action lawsuit filed by Bleichmar Fonti & Auld LLP. It's all about securities fraud—a dreaded term that no investor wants to hear. The...

Ad Council Expands Board, Taps Meta Exec as Vice Chair

An Unexpected Shuffle at the Ad Council Alright, folks, let's talk shop about the recent shake-up in the nonprofit realm. The Ad Council, which has been around longer than some of the giants controlling today's marketing landscapes, just plumped up its Board of Directors with 23 new heavy-hitters. We're talking about leaders from every nook and cranny of the...

FIU Cuba Poll: Cuban American Vote Leans GOP

Here we got the latest scoop from the 2026 FIU Cuba Poll, and boy, it's a wild ride. Picture this: 76% of Cuban Americans in South Florida aren't fans of Trump’s escalated deportations of Cubans sans criminal records, yet a solid 68% are sticking to their GOP guns come election season. Now, ain't that a head-scratcher? Cuban Americans and the GOP: A Complex Relationship...

Ferrovial's 2026 Growth: North America Drives Success

Solid Gains Across the Board Right off the bat, Ferrovial's 2026 report card screams 'win'. For the first three quarters, they clocked in a hefty 21.8% boost in adjusted EBITDA, and revenue didn't dawdle either, climbing 10.8%—not exactly a stroll in the park to accomplish. North America's No Joke Ferrovial's got a clear hero in their narrative and it's North America....

Fairfax Crest: A New Chapter in Affordable Housing

Setting the Stage: Fairfax Crest's Grand Opening You know what's better than leaving a dusty old car park underutilized? Turning it into homes for folks who really need them. That's exactly what went down in Fairfax County as they cut the ribbon on their latest affordable housing project, Fairfax Crest. We're talking 279 affordable units sprouting up where there once lay...

Antibiotic Overuse for Sinus Infections Costs Billions

Sinus Infections: A Case of Excess Prescriptions You'd think with all the guidelines, doctors would've nailed the sinusitis treatment by now. But nope—antibiotic overuse remains alive and kicking. A fresh dig from Motive Medical Intelligence shows that more than three-quarters of primary care clinicians are quick to hand out antibiotics for acute sinusitis. So here we...

Personalis Merger Faces Investigation: $16.25 Offers Scrutinized

Market Storm or Light Drizzle? When the sharks smell blood or the legal eagles start circling, you know something stinks. BFA Law is sniffing around, and it isn’t just for sport. They’re putting their magnifying glass on this curious $16.25 per share transaction where Tempus AI plans to gobble up Personalis lock, stock, and barrel. For investors holding NASDAQ:PSNL,...

UP Fintech Faces Class Action Over Alleged Misconduct

UP Fintech: A Financial Storm Brews When it rains, it sure pours. Investors are finding themselves stuck in the middle of a squall as UP Fintech Holding Limited's legal troubles unfold. Robbins LLP, a shareholder rights law firm, has filed a class-action lawsuit targeting UP Fintech (NASDAQ:TIGR), and the lawsuit isn't just some casual fling—it digs deep into the...

San Diego's Iconic Nightlife Venue Revives as The Quin

The ghosts of PLUXX's past are getting a new home at The Quin in San Diego. It's happening in the Gaslamp Quarter, where the familiar pulse of a party will hit the scene once again. Instead of peeling walls and the typical downtown club smell, we've got internationally acclaimed DJ Sam Feldt headlining the Halloween bash—Heaven & Hell. The Quin's Next Chapter Begins on...